We are talking about synthetic blood, for example for treating the wounded without the need to refrigerate and transport ...
Debut Biotech, a company innovating new molecules, is partnering with Image Skincare to launch a new beauty product, CNBC has learned. The San Diego-based company uses biotechnology and artificial ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
VC Versant Ventures is unveiling Dayra Therapeutics, a new biotech working on oral macrocyclic peptide drugs—a mission that has already reeled in a partnership with Biogen. The biopharma has paid $50 ...
A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...
In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Milwaukee Area Technical College has opened a biotechnology ...
Gov. Kathy Hochul on Tuesday unveiled four new initiatives to support biotech startups and accelerate drug development in New York, building on billions of dollars the state and city have already ...
Hosted on MSN
New biotech hub to drive disease-resistant crops
A centre of excellence for crop biotechnology is set be established to develop and deploy disease-resistant seeds under a new five-year project, according to the Ministry of Agriculture and Animal ...
For more than a decade, the New Orleans BioInnovation Center has worked to make its portion of Canal Street something entirely different from the retail corridor or hotel haven that it's been for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results